September 17, 2024
September 09, 2024
Telemedicine Shows Promise for Glaucoma Diagnosis
September 01, 2024
The Importance of Educating Staff About ATIOL Patient Education
September 05, 2024
Exercise's Impact on IOP: Jury Still Out
September 27, 2024
Study Examines Food Contact Chemicals in Humans
September 25, 2024
Travoprost Implants Go Head-to-Head with Timolol Drops in Phase 3 Trial
Latest Headlines
View More
September 27, 2024
Study Examines Food Contact Chemicals in Humans
September 25, 2024
Travoprost Implants Go Head-to-Head with Timolol Drops in Phase 3 Trial
September 25, 2024
Myopia Surge: 740 Million Youth Affected by 2050
September 25, 2024
Is CTG18.1 Instability the Key to FECD Progression?
September 24, 2024
SKG1108 Receives FDA Orphan Drug Designation
September 24, 2024
Clobetasol Soon to be Available in the US
Daily News
Stay up to date with the latest clinical headlines.
Trending Now
1
Can Hair Dye Cause Retinopathy?
2
Travoprost Implants Go Head-to-Head with Timolol Drops in Phase 3 Trial
3
Sickle Cell Drug Shows Promise in Stabilizing Vision in Rare Genetic Disease
4
Timolol Microdrops Show Comparable IOP-Lowering Efficacy to Conventional Drops
5
Clobetasol Soon to be Available in the US
6
EDVI Act Supports More Comprehensive Eye Care for Children
Conference Coverage
2024 Miami Breast Cancer Conference
Clinical Guidelines
View More
September 01, 2024
MASTERING MYOPIA
September 01, 2024
New Drug Therapies for Benign Retinal Tumors
August 30, 2024
CODING STRATEGY: The rules of refraction
November 01, 2023
What's New
Commentary & Perspectives
View More
September 24, 2024
Clobetasol Soon to be Available in the US
FDA & Government News
View More
September 24, 2024
SKG1108 Receives FDA Orphan Drug Designation
September 24, 2024
EDVI Act Supports More Comprehensive Eye Care for Children
September 23, 2024
MCO-010 Advances to Phase 3 for Stargardt Macular Degeneration
August 27, 2024
PCPs Play Important Role in Glaucoma Screening
Business Management
View More
September 01, 2024
The EB Optical Checklist
September 01, 2024
Industry Insider
September 01, 2024
Publisher's Letter
August 30, 2024